# A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

> clinical trial · VERIFIED · 2026-08-28

Status: RECRUITING · Sponsor: Janssen Research & Development, LLC · Condition: Leukemia, Myeloid, Acute

- Company: Janssen Research & Development, LLC
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06852222

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.